SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-17-007909
Filing Date
2017-05-04
Accepted
2017-05-04 07:02:25
Documents
61
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cbm20170331_10q.htm 10-Q 668736
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 12271
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 12649
4 EXHIBIT 32 ex32.htm EX-32 8669
  Complete submission text file 0001437749-17-007909.txt   4063667

Data Files

Seq Description Document Type Size
5 EXHIBIT 101.INS cbm-20170331.xml EX-101.INS 780757
6 EXHIBIT 101.SCH cbm-20170331.xsd EX-101.SCH 44669
7 EXHIBIT 101.CAL cbm-20170331_cal.xml EX-101.CAL 48134
8 EXHIBIT 101.DEF cbm-20170331_def.xml EX-101.DEF 324230
9 EXHIBIT 101.LAB cbm-20170331_lab.xml EX-101.LAB 284686
10 EXHIBIT 101.PRE cbm-20170331_pre.xml EX-101.PRE 347380
Mailing Address ONE MEADOWLANDS PLAZA E. RUTHERFORD NJ 07073
Business Address ONE MEADOWLANDS PLZ E RUTHERFORD NJ 07073 2018043000
CAMBREX CORP (Filer) CIK: 0000820081 (see all company filings)

IRS No.: 222476135 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10638 | Film No.: 17811767
SIC: 2834 Pharmaceutical Preparations